Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors

Cancer Letters

Volumn 183, Issue 1, 2002, Pages 43-51

  Cecic, Ivana ^a   Korbelik, Mladen ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Complement; Mouse EMT6 tumor; Neutrophilia; Photodynamic therapy

Indexed keywords

BLOOD CLOTTING FACTOR; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; PHOTOFRIN; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CELL COUNT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN INDUCTION; SARCOMA CELL; SOLID TUMOR;

ANIMALS; DIHEMATOPORPHYRIN ETHER; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, SCID; NEUTROPHILS; PHOTOCHEMOTHERAPY; SARCOMA, EXPERIMENTAL; TIME FACTORS;

EID: 0037044115     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00092-7     Document Type: Article

References (33)

1. Photodynamic therapy
2. Induction of tumor immunity by photodynamic therapy
3. Relevance of PDT-induced inflammatory response for the outcome of photodynamic therapy
4. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors
5. Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy
6. Nitric oxide production by tumour tissue: Impact on the response to photodynamic therapy
7. Altered expression of Interleukin 6 and Interleukin 10 as a result of photodynamic therapy in vivo
8. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy
9. Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone
10. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent
11. Reperfusion injury
12. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo
13. Interleukin-6 changes deformability of neutrophils and induces their sequestration in the lung
14. Generation of a monoclonal antibody to mouse C5: Application to an ELISA assay for detection of anti-C5 antibodies
15. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow
16. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: The roles of P-selectin and platelet activating factor
17. Biology of the complement system
18. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin
19. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors
20. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages
21. The effect of thromboxane inhibitors on the microvascular response to photodynamic therapy
22. 2 from cells by photodynamic therapy in vitro
23. Linkage between blood coagulation and inflammation: Stimulation of neutrophil tissue kallikrein by thrombin
24. Purified plasma factor XII aggregates human neutrophils and causes degranulation
25. Kallikrein and kinin receptor expression in inflammation and cancer
26. Altered neutrophil homeostasis in kinin B1 receptor-deficient mice
27. Inhibition of poly(ADP-ribose)synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects
28. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model?
29. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration
30. The role of inflammatory cytokines in the response of solid cancers to photodynamic therapy
31. Mechanistic principles of photodynamic therapy
32. Mechanism of tumor destruction by photodynamic therapy
33. Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1